nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.0018	0.00832	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL27—atopic dermatitis	0.00176	0.00816	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL27—atopic dermatitis	0.00172	0.00799	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCL11—atopic dermatitis	0.0017	0.00789	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00167	0.00775	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00164	0.0076	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00164	0.0076	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00164	0.00758	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00162	0.00753	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00162	0.00753	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00162	0.0075	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00161	0.00744	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00161	0.00744	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00159	0.00738	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00159	0.00737	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL17—atopic dermatitis	0.00158	0.00732	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00156	0.00721	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL17—atopic dermatitis	0.00155	0.00716	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00139	0.00646	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00139	0.00644	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCR3—atopic dermatitis	0.00139	0.00643	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00136	0.00631	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00136	0.00631	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL22—atopic dermatitis	0.00136	0.00628	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00133	0.00618	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCL27—atopic dermatitis	0.00133	0.00617	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00129	0.00598	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00129	0.00597	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL11—atopic dermatitis	0.00127	0.0059	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00126	0.00582	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL11—atopic dermatitis	0.00125	0.00577	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—NPS—atopic dermatitis	0.00124	0.00573	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—TAC1—atopic dermatitis	0.00124	0.00573	CbGpPWpGaD
Bimatoprost—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00123	0.00156	CcSEcCtD
Bimatoprost—Nervous system disorder—Loratadine—atopic dermatitis	0.00122	0.00155	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00121	0.00563	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00121	0.00563	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCR3—atopic dermatitis	0.00121	0.00562	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL27—atopic dermatitis	0.00121	0.0056	CbGpPWpGaD
Bimatoprost—Skin disorder—Loratadine—atopic dermatitis	0.0012	0.00153	CcSEcCtD
Bimatoprost—Rhinitis—Tacrolimus—atopic dermatitis	0.00119	0.00152	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00119	0.00552	CbGpPWpGaD
Bimatoprost—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00119	0.00152	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00119	0.00551	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00119	0.00551	CbGpPWpGaD
Bimatoprost—Pharyngitis—Tacrolimus—atopic dermatitis	0.00118	0.00151	CcSEcCtD
Bimatoprost—Dizziness—Fluocinonide—atopic dermatitis	0.00118	0.0015	CcSEcCtD
Bimatoprost—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00117	0.0015	CcSEcCtD
Bimatoprost—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.00117	0.00149	CcSEcCtD
Bimatoprost—Dry eye—Betamethasone—atopic dermatitis	0.00117	0.00149	CcSEcCtD
Bimatoprost—Dry eye—Dexamethasone—atopic dermatitis	0.00117	0.00149	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00117	0.0054	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00117	0.0054	CbGpPWpGaD
Bimatoprost—Hypercholesterolaemia—Prednisone—atopic dermatitis	0.00116	0.00148	CcSEcCtD
Bimatoprost—Visual disturbance—Prednisolone—atopic dermatitis	0.00116	0.00148	CcSEcCtD
Bimatoprost—Cataract—Prednisone—atopic dermatitis	0.00116	0.00148	CcSEcCtD
Bimatoprost—Asthenia—Dimenhydrinate—atopic dermatitis	0.00115	0.00147	CcSEcCtD
Bimatoprost—Asthenia—Diphenhydramine—atopic dermatitis	0.00115	0.00147	CcSEcCtD
Bimatoprost—Visual impairment—Tacrolimus—atopic dermatitis	0.00115	0.00146	CcSEcCtD
Bimatoprost—Cough—Mometasone—atopic dermatitis	0.00114	0.00145	CcSEcCtD
Bimatoprost—Rash—Fluocinonide—atopic dermatitis	0.00113	0.00143	CcSEcCtD
Bimatoprost—Dermatitis—Fluocinonide—atopic dermatitis	0.00112	0.00143	CcSEcCtD
Bimatoprost—Insomnia—Loratadine—atopic dermatitis	0.00112	0.00143	CcSEcCtD
Bimatoprost—Headache—Fluocinonide—atopic dermatitis	0.00112	0.00143	CcSEcCtD
Bimatoprost—Eye disorder—Tacrolimus—atopic dermatitis	0.00111	0.00142	CcSEcCtD
Bimatoprost—Chest pain—Mometasone—atopic dermatitis	0.00111	0.00141	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00111	0.00514	CbGpPWpGaD
Bimatoprost—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00111	0.00141	CcSEcCtD
Bimatoprost—Somnolence—Loratadine—atopic dermatitis	0.0011	0.0014	CcSEcCtD
Bimatoprost—Pruritus—Pimecrolimus—atopic dermatitis	0.0011	0.0014	CcSEcCtD
Bimatoprost—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00109	0.00139	CcSEcCtD
Bimatoprost—Dyspepsia—Loratadine—atopic dermatitis	0.00109	0.00139	CcSEcCtD
Bimatoprost—Dry mouth—Mometasone—atopic dermatitis	0.00108	0.00138	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCL17—atopic dermatitis	0.00108	0.00502	CbGpPWpGaD
Bimatoprost—Angiopathy—Tacrolimus—atopic dermatitis	0.00108	0.00138	CcSEcCtD
Bimatoprost—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.00107	0.00137	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00107	0.00136	CcSEcCtD
Bimatoprost—Dizziness—Diphenhydramine—atopic dermatitis	0.00106	0.00136	CcSEcCtD
Bimatoprost—Dizziness—Dimenhydrinate—atopic dermatitis	0.00106	0.00136	CcSEcCtD
Bimatoprost—Pain—Loratadine—atopic dermatitis	0.00106	0.00135	CcSEcCtD
Bimatoprost—Infection—Mometasone—atopic dermatitis	0.00106	0.00135	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCR3—atopic dermatitis	0.00104	0.00481	CbGpPWpGaD
Bimatoprost—Erythema—Tacrolimus—atopic dermatitis	0.00104	0.00132	CcSEcCtD
Bimatoprost—Tension—Tacrolimus—atopic dermatitis	0.00102	0.0013	CcSEcCtD
Bimatoprost—Eye pain—Dexamethasone—atopic dermatitis	0.00102	0.0013	CcSEcCtD
Bimatoprost—Eye pain—Betamethasone—atopic dermatitis	0.00102	0.0013	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR3—atopic dermatitis	0.00102	0.00471	CbGpPWpGaD
Bimatoprost—Rash—Dimenhydrinate—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Rash—Diphenhydramine—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL22—atopic dermatitis	0.00101	0.0047	CbGpPWpGaD
Bimatoprost—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Dermatitis—Diphenhydramine—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Dry skin—Prednisolone—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Headache—Dimenhydrinate—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Headache—Diphenhydramine—atopic dermatitis	0.00101	0.00129	CcSEcCtD
Bimatoprost—Nervousness—Tacrolimus—atopic dermatitis	0.00101	0.00128	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000998	0.00463	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000995	0.00461	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL22—atopic dermatitis	0.000992	0.0046	CbGpPWpGaD
Bimatoprost—Dry skin—Hydrocortisone—atopic dermatitis	0.000985	0.00126	CcSEcCtD
Bimatoprost—Rash—Pimecrolimus—atopic dermatitis	0.000981	0.00125	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL10—atopic dermatitis	0.00098	0.00454	CbGpPWpGaD
Bimatoprost—Dermatitis—Pimecrolimus—atopic dermatitis	0.00098	0.00125	CcSEcCtD
Bimatoprost—Vision blurred—Tacrolimus—atopic dermatitis	0.000977	0.00125	CcSEcCtD
Bimatoprost—Headache—Pimecrolimus—atopic dermatitis	0.000975	0.00124	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000974	0.00451	CbGpPWpGaD
Bimatoprost—Visual disturbance—Dexamethasone—atopic dermatitis	0.000969	0.00124	CcSEcCtD
Bimatoprost—Visual disturbance—Betamethasone—atopic dermatitis	0.000969	0.00124	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000963	0.00446	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000961	0.00123	CcSEcCtD
Bimatoprost—Nausea—Dimenhydrinate—atopic dermatitis	0.000956	0.00122	CcSEcCtD
Bimatoprost—Nausea—Diphenhydramine—atopic dermatitis	0.000956	0.00122	CcSEcCtD
Bimatoprost—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000952	0.00121	CcSEcCtD
Bimatoprost—Dyspnoea—Mometasone—atopic dermatitis	0.000948	0.00121	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000942	0.00437	CbGpPWpGaD
Bimatoprost—Dyspepsia—Mometasone—atopic dermatitis	0.000936	0.00119	CcSEcCtD
Bimatoprost—Vertigo—Tacrolimus—atopic dermatitis	0.000932	0.00119	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—TAC1—atopic dermatitis	0.000925	0.00429	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—NPS—atopic dermatitis	0.000925	0.00429	CbGpPWpGaD
Bimatoprost—Nausea—Pimecrolimus—atopic dermatitis	0.000924	0.00118	CcSEcCtD
Bimatoprost—Palpitations—Tacrolimus—atopic dermatitis	0.000916	0.00117	CcSEcCtD
Bimatoprost—Pain—Mometasone—atopic dermatitis	0.000909	0.00116	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CXCR3—atopic dermatitis	0.000907	0.0042	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—NPS—atopic dermatitis	0.000905	0.0042	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—TAC1—atopic dermatitis	0.000905	0.0042	CbGpPWpGaD
Bimatoprost—Cough—Tacrolimus—atopic dermatitis	0.000905	0.00115	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL27—atopic dermatitis	0.000904	0.00419	CbGpPWpGaD
Bimatoprost—Hypertension—Tacrolimus—atopic dermatitis	0.000895	0.00114	CcSEcCtD
Bimatoprost—Asthenia—Loratadine—atopic dermatitis	0.000889	0.00113	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000888	0.00411	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL27—atopic dermatitis	0.000884	0.0041	CbGpPWpGaD
Bimatoprost—Chest pain—Tacrolimus—atopic dermatitis	0.000883	0.00113	CcSEcCtD
Bimatoprost—Anxiety—Tacrolimus—atopic dermatitis	0.00088	0.00112	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000877	0.00112	CcSEcCtD
Bimatoprost—Asthma—Triamcinolone—atopic dermatitis	0.000874	0.00111	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCL11—atopic dermatitis	0.000874	0.00405	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000871	0.00404	CbGpPWpGaD
Bimatoprost—Dry mouth—Tacrolimus—atopic dermatitis	0.000863	0.0011	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000863	0.0011	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—FCER2—atopic dermatitis	0.000861	0.00399	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000853	0.00395	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCL5—atopic dermatitis	0.000844	0.00391	CbGpPWpGaD
Bimatoprost—Dry skin—Dexamethasone—atopic dermatitis	0.000841	0.00107	CcSEcCtD
Bimatoprost—Dry skin—Betamethasone—atopic dermatitis	0.000841	0.00107	CcSEcCtD
Bimatoprost—Infection—Tacrolimus—atopic dermatitis	0.000841	0.00107	CcSEcCtD
Bimatoprost—Bronchitis—Triamcinolone—atopic dermatitis	0.000841	0.00107	CcSEcCtD
Bimatoprost—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00083	0.00106	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000829	0.00384	CbGpPWpGaD
Bimatoprost—Skin disorder—Tacrolimus—atopic dermatitis	0.000822	0.00105	CcSEcCtD
Bimatoprost—Dizziness—Loratadine—atopic dermatitis	0.000819	0.00104	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000813	0.00104	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000811	0.00376	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL17—atopic dermatitis	0.00081	0.00376	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL22—atopic dermatitis	0.000801	0.00371	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL17—atopic dermatitis	0.000793	0.00368	CbGpPWpGaD
Bimatoprost—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000788	0.001	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR3—atopic dermatitis	0.000784	0.00363	CbGpPWpGaD
Bimatoprost—Rash—Loratadine—atopic dermatitis	0.000781	0.000996	CcSEcCtD
Bimatoprost—Dermatitis—Loratadine—atopic dermatitis	0.000781	0.000995	CcSEcCtD
Bimatoprost—Headache—Loratadine—atopic dermatitis	0.000776	0.00099	CcSEcCtD
Bimatoprost—Insomnia—Tacrolimus—atopic dermatitis	0.000766	0.000976	CcSEcCtD
Bimatoprost—Asthenia—Mometasone—atopic dermatitis	0.000763	0.000973	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CCR5—atopic dermatitis	0.00076	0.00352	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000759	0.00352	CbGpPWpGaD
Bimatoprost—Dyspnoea—Tacrolimus—atopic dermatitis	0.000755	0.000962	CcSEcCtD
Bimatoprost—Somnolence—Tacrolimus—atopic dermatitis	0.000752	0.000959	CcSEcCtD
Bimatoprost—Pruritus—Mometasone—atopic dermatitis	0.000752	0.000959	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000747	0.00346	CbGpPWpGaD
Bimatoprost—Dyspepsia—Tacrolimus—atopic dermatitis	0.000745	0.00095	CcSEcCtD
Bimatoprost—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000736	0.000939	CcSEcCtD
Bimatoprost—Nausea—Loratadine—atopic dermatitis	0.000736	0.000939	CcSEcCtD
Bimatoprost—Visual impairment—Prednisolone—atopic dermatitis	0.000733	0.000935	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000733	0.0034	CbGpPWpGaD
Bimatoprost—Dry skin—Prednisone—atopic dermatitis	0.000733	0.000934	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000731	0.00339	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000731	0.000932	CcSEcCtD
Bimatoprost—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00073	0.000931	CcSEcCtD
Bimatoprost—Pain—Tacrolimus—atopic dermatitis	0.000724	0.000923	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000718	0.00333	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL27—atopic dermatitis	0.000714	0.00331	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCR3—atopic dermatitis	0.000712	0.0033	CbGpPWpGaD
Bimatoprost—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000702	0.000895	CcSEcCtD
Bimatoprost—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000702	0.000895	CcSEcCtD
Bimatoprost—Rhinitis—Triamcinolone—atopic dermatitis	0.000702	0.000895	CcSEcCtD
Bimatoprost—Rhinitis—Methylprednisolone—atopic dermatitis	0.0007	0.000893	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—TAC1—atopic dermatitis	0.000699	0.00324	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—NPS—atopic dermatitis	0.000699	0.00324	CbGpPWpGaD
Bimatoprost—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000698	0.00089	CcSEcCtD
Bimatoprost—Pharyngitis—Triamcinolone—atopic dermatitis	0.000695	0.000886	CcSEcCtD
Bimatoprost—Eye disorder—Hydrocortisone—atopic dermatitis	0.000695	0.000886	CcSEcCtD
Bimatoprost—AKR1C3—Disease—GLB1—atopic dermatitis	0.000687	0.00318	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000686	0.000875	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000685	0.00318	CbGpPWpGaD
Bimatoprost—Visual impairment—Methylprednisolone—atopic dermatitis	0.000673	0.000858	CcSEcCtD
Bimatoprost—Rash—Mometasone—atopic dermatitis	0.000671	0.000855	CcSEcCtD
Bimatoprost—Dermatitis—Mometasone—atopic dermatitis	0.00067	0.000854	CcSEcCtD
Bimatoprost—Headache—Mometasone—atopic dermatitis	0.000666	0.00085	CcSEcCtD
Bimatoprost—Erythema—Prednisolone—atopic dermatitis	0.000662	0.000845	CcSEcCtD
Bimatoprost—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000662	0.000844	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL11—atopic dermatitis	0.000653	0.00303	CbGpPWpGaD
Bimatoprost—Eye disorder—Methylprednisolone—atopic dermatitis	0.000653	0.000832	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—IL5—atopic dermatitis	0.00065	0.00301	CbGpPWpGaD
Bimatoprost—Erythema—Hydrocortisone—atopic dermatitis	0.000647	0.000825	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—FCER2—atopic dermatitis	0.000644	0.00299	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL17—atopic dermatitis	0.00064	0.00297	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL11—atopic dermatitis	0.000639	0.00296	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—TAC1—atopic dermatitis	0.000635	0.00294	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—NPS—atopic dermatitis	0.000635	0.00294	CbGpPWpGaD
Bimatoprost—Angiopathy—Methylprednisolone—atopic dermatitis	0.000633	0.000808	CcSEcCtD
Bimatoprost—Nausea—Mometasone—atopic dermatitis	0.000632	0.000805	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCL5—atopic dermatitis	0.000631	0.00292	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FCER2—atopic dermatitis	0.00063	0.00292	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000629	0.000802	CcSEcCtD
Bimatoprost—Vision blurred—Prednisolone—atopic dermatitis	0.000624	0.000796	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CXCR3—atopic dermatitis	0.000622	0.00288	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL5—atopic dermatitis	0.000618	0.00286	CbGpPWpGaD
Bimatoprost—Depression—Prednisone—atopic dermatitis	0.000614	0.000783	CcSEcCtD
Bimatoprost—Visual impairment—Dexamethasone—atopic dermatitis	0.000612	0.00078	CcSEcCtD
Bimatoprost—Visual impairment—Betamethasone—atopic dermatitis	0.000612	0.00078	CcSEcCtD
Bimatoprost—Erythema—Triamcinolone—atopic dermatitis	0.000609	0.000777	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—FCER2—atopic dermatitis	0.000608	0.00282	CbGpPWpGaD
Bimatoprost—Erythema—Methylprednisolone—atopic dermatitis	0.000608	0.000775	CcSEcCtD
Bimatoprost—Asthenia—Tacrolimus—atopic dermatitis	0.000607	0.000774	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000604	0.0028	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL22—atopic dermatitis	0.000599	0.00278	CbGpPWpGaD
Bimatoprost—Pruritus—Tacrolimus—atopic dermatitis	0.000599	0.000764	CcSEcCtD
Bimatoprost—Vertigo—Prednisolone—atopic dermatitis	0.000595	0.000759	CcSEcCtD
Bimatoprost—Eye disorder—Betamethasone—atopic dermatitis	0.000593	0.000757	CcSEcCtD
Bimatoprost—Eye disorder—Dexamethasone—atopic dermatitis	0.000593	0.000757	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—IL5—atopic dermatitis	0.00059	0.00273	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000586	0.00272	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL22—atopic dermatitis	0.000586	0.00272	CbGpPWpGaD
Bimatoprost—Vertigo—Hydrocortisone—atopic dermatitis	0.000581	0.000741	CcSEcCtD
Bimatoprost—Angiopathy—Betamethasone—atopic dermatitis	0.000576	0.000735	CcSEcCtD
Bimatoprost—Angiopathy—Dexamethasone—atopic dermatitis	0.000576	0.000735	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GLB1—atopic dermatitis	0.000575	0.00267	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000574	0.00266	CbGpPWpGaD
Bimatoprost—Hypertension—Prednisolone—atopic dermatitis	0.000572	0.000729	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—KIF3A—atopic dermatitis	0.000571	0.00264	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCR5—atopic dermatitis	0.000569	0.00263	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL22—atopic dermatitis	0.000566	0.00262	CbGpPWpGaD
Bimatoprost—Dizziness—Tacrolimus—atopic dermatitis	0.00056	0.000714	CcSEcCtD
Bimatoprost—Hypertension—Hydrocortisone—atopic dermatitis	0.000559	0.000712	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR5—atopic dermatitis	0.000557	0.00258	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000554	0.00257	CbGpPWpGaD
Bimatoprost—Erythema—Dexamethasone—atopic dermatitis	0.000553	0.000705	CcSEcCtD
Bimatoprost—Erythema—Betamethasone—atopic dermatitis	0.000553	0.000705	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—ADSL—atopic dermatitis	0.000551	0.00256	CbGpPWpGaD
Bimatoprost—Anxiety—Hydrocortisone—atopic dermatitis	0.000549	0.0007	CcSEcCtD
Bimatoprost—Vertigo—Triamcinolone—atopic dermatitis	0.000547	0.000698	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000547	0.000697	CcSEcCtD
Bimatoprost—Vertigo—Methylprednisolone—atopic dermatitis	0.000546	0.000696	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—atopic dermatitis	0.000543	0.000693	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CCL27—atopic dermatitis	0.000534	0.00247	CbGpPWpGaD
Bimatoprost—Rash—Tacrolimus—atopic dermatitis	0.000534	0.000681	CcSEcCtD
Bimatoprost—Dermatitis—Tacrolimus—atopic dermatitis	0.000533	0.00068	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCR3—atopic dermatitis	0.000532	0.00247	CbGpPWpGaD
Bimatoprost—Cough—Triamcinolone—atopic dermatitis	0.000532	0.000678	CcSEcCtD
Bimatoprost—Headache—Tacrolimus—atopic dermatitis	0.00053	0.000676	CcSEcCtD
Bimatoprost—Hypertension—Triamcinolone—atopic dermatitis	0.000526	0.000671	CcSEcCtD
Bimatoprost—Hypertension—Methylprednisolone—atopic dermatitis	0.000525	0.000669	CcSEcCtD
Bimatoprost—Infection—Hydrocortisone—atopic dermatitis	0.000525	0.000669	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000523	0.00242	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—NPS—atopic dermatitis	0.000523	0.00242	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL27—atopic dermatitis	0.000522	0.00242	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR3—atopic dermatitis	0.000521	0.00242	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000518	0.00066	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—atopic dermatitis	0.000517	0.000659	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CMA1—atopic dermatitis	0.000516	0.00239	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL11—atopic dermatitis	0.000516	0.00239	CbGpPWpGaD
Bimatoprost—Anxiety—Methylprednisolone—atopic dermatitis	0.000516	0.000658	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000514	0.000655	CcSEcCtD
Bimatoprost—Skin disorder—Hydrocortisone—atopic dermatitis	0.000513	0.000654	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000513	0.00238	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—NPS—atopic dermatitis	0.000512	0.00237	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000512	0.00237	CbGpPWpGaD
Bimatoprost—Dry mouth—Triamcinolone—atopic dermatitis	0.000507	0.000647	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—CCL27—atopic dermatitis	0.000504	0.00234	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL10—atopic dermatitis	0.000503	0.00233	CbGpPWpGaD
Bimatoprost—Nausea—Tacrolimus—atopic dermatitis	0.000503	0.000641	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000502	0.00233	CbGpPWpGaD
Bimatoprost—Angiopathy—Prednisone—atopic dermatitis	0.000502	0.00064	CcSEcCtD
Bimatoprost—Vertigo—Dexamethasone—atopic dermatitis	0.000497	0.000633	CcSEcCtD
Bimatoprost—Vertigo—Betamethasone—atopic dermatitis	0.000497	0.000633	CcSEcCtD
Bimatoprost—Infection—Triamcinolone—atopic dermatitis	0.000494	0.00063	CcSEcCtD
Bimatoprost—Infection—Methylprednisolone—atopic dermatitis	0.000493	0.000628	CcSEcCtD
Bimatoprost—Insomnia—Prednisolone—atopic dermatitis	0.000489	0.000624	CcSEcCtD
Bimatoprost—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000486	0.00062	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—IL5—atopic dermatitis	0.000486	0.00225	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT6—atopic dermatitis	0.000485	0.00225	CbGpPWpGaD
Bimatoprost—Skin disorder—Methylprednisolone—atopic dermatitis	0.000482	0.000614	CcSEcCtD
Bimatoprost—Erythema—Prednisone—atopic dermatitis	0.000481	0.000614	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CCL17—atopic dermatitis	0.000479	0.00222	CbGpPWpGaD
Bimatoprost—Insomnia—Hydrocortisone—atopic dermatitis	0.000478	0.000609	CcSEcCtD
Bimatoprost—Hypertension—Dexamethasone—atopic dermatitis	0.000477	0.000609	CcSEcCtD
Bimatoprost—Hypertension—Betamethasone—atopic dermatitis	0.000477	0.000609	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CCL5—atopic dermatitis	0.000477	0.00221	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL5—atopic dermatitis	0.000476	0.0022	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—NPS—atopic dermatitis	0.000475	0.0022	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TAC1—atopic dermatitis	0.000475	0.0022	CbGpPWpGaD
Bimatoprost—Anxiety—Dexamethasone—atopic dermatitis	0.000469	0.000598	CcSEcCtD
Bimatoprost—Anxiety—Betamethasone—atopic dermatitis	0.000469	0.000598	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CCL17—atopic dermatitis	0.000469	0.00217	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000465	0.00216	CbGpPWpGaD
Bimatoprost—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000465	0.000593	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—NPS—atopic dermatitis	0.000465	0.00215	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TAC1—atopic dermatitis	0.000465	0.00215	CbGpPWpGaD
Bimatoprost—Pain—Prednisolone—atopic dermatitis	0.000462	0.00059	CcSEcCtD
Bimatoprost—AKR1C3—Disease—SLC11A1—atopic dermatitis	0.00046	0.00213	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL8—atopic dermatitis	0.00046	0.00213	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000456	0.000581	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000456	0.00211	CbGpPWpGaD
Bimatoprost—Vision blurred—Prednisone—atopic dermatitis	0.000454	0.000578	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—CCL17—atopic dermatitis	0.000452	0.0021	CbGpPWpGaD
Bimatoprost—Pain—Hydrocortisone—atopic dermatitis	0.000452	0.000576	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000451	0.00209	CbGpPWpGaD
Bimatoprost—Insomnia—Triamcinolone—atopic dermatitis	0.00045	0.000573	CcSEcCtD
Bimatoprost—Insomnia—Methylprednisolone—atopic dermatitis	0.000449	0.000572	CcSEcCtD
Bimatoprost—Infection—Dexamethasone—atopic dermatitis	0.000448	0.000571	CcSEcCtD
Bimatoprost—Infection—Betamethasone—atopic dermatitis	0.000448	0.000571	CcSEcCtD
Bimatoprost—Dyspnoea—Triamcinolone—atopic dermatitis	0.000443	0.000565	CcSEcCtD
Bimatoprost—Nervous system disorder—Betamethasone—atopic dermatitis	0.000442	0.000564	CcSEcCtD
Bimatoprost—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000442	0.000564	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000442	0.00205	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL5—atopic dermatitis	0.000441	0.00204	CbGpPWpGaD
Bimatoprost—Dyspepsia—Triamcinolone—atopic dermatitis	0.000438	0.000558	CcSEcCtD
Bimatoprost—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000437	0.000557	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCL5—atopic dermatitis	0.000433	0.00201	CbGpPWpGaD
Bimatoprost—Vertigo—Prednisone—atopic dermatitis	0.000432	0.000551	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—IL5—atopic dermatitis	0.000432	0.002	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR5—atopic dermatitis	0.00043	0.00199	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KIF3A—atopic dermatitis	0.000427	0.00198	CbGpPWpGaD
Bimatoprost—Pain—Triamcinolone—atopic dermatitis	0.000425	0.000542	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CCR3—atopic dermatitis	0.000421	0.00195	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000419	0.00194	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KIF3A—atopic dermatitis	0.000418	0.00194	CbGpPWpGaD
Bimatoprost—Hypertension—Prednisone—atopic dermatitis	0.000416	0.00053	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000414	0.00192	CbGpPWpGaD
Bimatoprost—Anxiety—Prednisone—atopic dermatitis	0.000408	0.000521	CcSEcCtD
Bimatoprost—Insomnia—Dexamethasone—atopic dermatitis	0.000408	0.00052	CcSEcCtD
Bimatoprost—Insomnia—Betamethasone—atopic dermatitis	0.000408	0.00052	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000407	0.000519	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000406	0.00188	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KIF3A—atopic dermatitis	0.000403	0.00187	CbGpPWpGaD
Bimatoprost—Dyspepsia—Betamethasone—atopic dermatitis	0.000397	0.000506	CcSEcCtD
Bimatoprost—Dyspepsia—Dexamethasone—atopic dermatitis	0.000397	0.000506	CcSEcCtD
Bimatoprost—Infection—Prednisone—atopic dermatitis	0.00039	0.000498	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCR5—atopic dermatitis	0.00039	0.00181	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000389	0.000497	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000389	0.000497	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CCL11—atopic dermatitis	0.000386	0.00179	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CMA1—atopic dermatitis	0.000386	0.00179	CbGpPWpGaD
Bimatoprost—Pain—Betamethasone—atopic dermatitis	0.000386	0.000492	CcSEcCtD
Bimatoprost—Pain—Dexamethasone—atopic dermatitis	0.000386	0.000492	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—atopic dermatitis	0.000385	0.000491	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—atopic dermatitis	0.000382	0.000487	CcSEcCtD
Bimatoprost—Asthenia—Hydrocortisone—atopic dermatitis	0.000379	0.000483	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CCL11—atopic dermatitis	0.000378	0.00175	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CMA1—atopic dermatitis	0.000378	0.00175	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000376	0.00174	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NPS—atopic dermatitis	0.000375	0.00174	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TAC1—atopic dermatitis	0.000375	0.00174	CbGpPWpGaD
Bimatoprost—Pruritus—Hydrocortisone—atopic dermatitis	0.000374	0.000476	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000368	0.00171	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCR3—atopic dermatitis	0.000368	0.0017	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL11—atopic dermatitis	0.000364	0.00169	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CMA1—atopic dermatitis	0.000364	0.00169	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT6—atopic dermatitis	0.000363	0.00168	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisolone—atopic dermatitis	0.000358	0.000456	CcSEcCtD
Bimatoprost—Asthenia—Triamcinolone—atopic dermatitis	0.000357	0.000455	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000357	0.00165	CbGpPWpGaD
Bimatoprost—Asthenia—Methylprednisolone—atopic dermatitis	0.000356	0.000454	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—atopic dermatitis	0.000355	0.000453	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—STAT6—atopic dermatitis	0.000355	0.00165	CbGpPWpGaD
Bimatoprost—Pruritus—Triamcinolone—atopic dermatitis	0.000352	0.000449	CcSEcCtD
Bimatoprost—Pruritus—Methylprednisolone—atopic dermatitis	0.000351	0.000448	CcSEcCtD
Bimatoprost—Dizziness—Hydrocortisone—atopic dermatitis	0.000349	0.000445	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000349	0.00162	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL5—atopic dermatitis	0.000349	0.00162	CbGpPWpGaD
Bimatoprost—Dyspepsia—Prednisone—atopic dermatitis	0.000346	0.000441	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000344	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT6—atopic dermatitis	0.000343	0.00159	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000342	0.00159	CbGpPWpGaD
Bimatoprost—Rash—Prednisolone—atopic dermatitis	0.000341	0.000435	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—atopic dermatitis	0.000341	0.000434	CcSEcCtD
Bimatoprost—Headache—Prednisolone—atopic dermatitis	0.000339	0.000432	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000336	0.00156	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000335	0.00155	CbGpPWpGaD
Bimatoprost—Rash—Hydrocortisone—atopic dermatitis	0.000333	0.000425	CcSEcCtD
Bimatoprost—Dermatitis—Hydrocortisone—atopic dermatitis	0.000333	0.000424	CcSEcCtD
Bimatoprost—Headache—Hydrocortisone—atopic dermatitis	0.000331	0.000422	CcSEcCtD
Bimatoprost—Dizziness—Triamcinolone—atopic dermatitis	0.000329	0.000419	CcSEcCtD
Bimatoprost—Dizziness—Methylprednisolone—atopic dermatitis	0.000328	0.000418	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL5—atopic dermatitis	0.000324	0.0015	CbGpPWpGaD
Bimatoprost—Asthenia—Dexamethasone—atopic dermatitis	0.000324	0.000413	CcSEcCtD
Bimatoprost—Asthenia—Betamethasone—atopic dermatitis	0.000324	0.000413	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000321	0.00149	CbGpPWpGaD
Bimatoprost—Nausea—Prednisolone—atopic dermatitis	0.000321	0.000409	CcSEcCtD
Bimatoprost—Pruritus—Betamethasone—atopic dermatitis	0.000319	0.000407	CcSEcCtD
Bimatoprost—Pruritus—Dexamethasone—atopic dermatitis	0.000319	0.000407	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCL5—atopic dermatitis	0.000317	0.00147	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR3—atopic dermatitis	0.000315	0.00146	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000314	0.00146	CbGpPWpGaD
Bimatoprost—Nausea—Hydrocortisone—atopic dermatitis	0.000314	0.0004	CcSEcCtD
Bimatoprost—Rash—Triamcinolone—atopic dermatitis	0.000313	0.0004	CcSEcCtD
Bimatoprost—Dermatitis—Triamcinolone—atopic dermatitis	0.000313	0.000399	CcSEcCtD
Bimatoprost—Rash—Methylprednisolone—atopic dermatitis	0.000313	0.000399	CcSEcCtD
Bimatoprost—Dermatitis—Methylprednisolone—atopic dermatitis	0.000312	0.000398	CcSEcCtD
Bimatoprost—Headache—Triamcinolone—atopic dermatitis	0.000311	0.000397	CcSEcCtD
Bimatoprost—Headache—Methylprednisolone—atopic dermatitis	0.000311	0.000396	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CCR3—atopic dermatitis	0.000308	0.00143	CbGpPWpGaD
Bimatoprost—Dizziness—Betamethasone—atopic dermatitis	0.000298	0.00038	CcSEcCtD
Bimatoprost—Dizziness—Dexamethasone—atopic dermatitis	0.000298	0.00038	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CXCL10—atopic dermatitis	0.000297	0.00138	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR3—atopic dermatitis	0.000297	0.00138	CbGpPWpGaD
Bimatoprost—Nausea—Triamcinolone—atopic dermatitis	0.000295	0.000377	CcSEcCtD
Bimatoprost—Nausea—Methylprednisolone—atopic dermatitis	0.000295	0.000376	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCR5—atopic dermatitis	0.000292	0.00135	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR5—atopic dermatitis	0.000286	0.00132	CbGpPWpGaD
Bimatoprost—Rash—Betamethasone—atopic dermatitis	0.000284	0.000363	CcSEcCtD
Bimatoprost—Rash—Dexamethasone—atopic dermatitis	0.000284	0.000363	CcSEcCtD
Bimatoprost—Dermatitis—Dexamethasone—atopic dermatitis	0.000284	0.000362	CcSEcCtD
Bimatoprost—Dermatitis—Betamethasone—atopic dermatitis	0.000284	0.000362	CcSEcCtD
Bimatoprost—Headache—Betamethasone—atopic dermatitis	0.000283	0.00036	CcSEcCtD
Bimatoprost—Headache—Dexamethasone—atopic dermatitis	0.000283	0.00036	CcSEcCtD
Bimatoprost—Asthenia—Prednisone—atopic dermatitis	0.000282	0.000359	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—TAC1—atopic dermatitis	0.00028	0.0013	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NPS—atopic dermatitis	0.00028	0.0013	CbGpPWpGaD
Bimatoprost—Pruritus—Prednisone—atopic dermatitis	0.000278	0.000354	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CXCR3—atopic dermatitis	0.000275	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NPS—atopic dermatitis	0.000274	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TAC1—atopic dermatitis	0.000274	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCR3—atopic dermatitis	0.000269	0.00125	CbGpPWpGaD
Bimatoprost—Nausea—Betamethasone—atopic dermatitis	0.000268	0.000342	CcSEcCtD
Bimatoprost—Nausea—Dexamethasone—atopic dermatitis	0.000268	0.000342	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—NPS—atopic dermatitis	0.000265	0.00123	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TAC1—atopic dermatitis	0.000265	0.00123	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL5—atopic dermatitis	0.000261	0.00121	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisone—atopic dermatitis	0.00026	0.000331	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.00026	0.0012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCR3—atopic dermatitis	0.00026	0.0012	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL5—atopic dermatitis	0.000256	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL5—atopic dermatitis	0.000255	0.00118	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2—atopic dermatitis	0.000248	0.00115	CbGpPWpGaD
Bimatoprost—Rash—Prednisone—atopic dermatitis	0.000248	0.000316	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—atopic dermatitis	0.000247	0.000316	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—IL5—atopic dermatitis	0.000246	0.00114	CbGpPWpGaD
Bimatoprost—Headache—Prednisone—atopic dermatitis	0.000246	0.000314	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NGF—atopic dermatitis	0.000237	0.0011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—atopic dermatitis	0.000236	0.00109	CbGpPWpGaD
Bimatoprost—Nausea—Prednisone—atopic dermatitis	0.000233	0.000298	CcSEcCtD
Bimatoprost—AKR1C3—Disease—CCR5—atopic dermatitis	0.000232	0.00108	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR5—atopic dermatitis	0.00023	0.00107	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—atopic dermatitis	0.000225	0.00104	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL10—atopic dermatitis	0.000222	0.00103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL10—atopic dermatitis	0.000218	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL10—atopic dermatitis	0.00021	0.000973	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000195	0.000906	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000194	0.0009	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL5—atopic dermatitis	0.000191	0.000887	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.00019	0.000881	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL5—atopic dermatitis	0.000187	0.000868	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARA—atopic dermatitis	0.000187	0.000865	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—atopic dermatitis	0.000186	0.00086	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—atopic dermatitis	0.000182	0.000842	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL5—atopic dermatitis	0.000181	0.000837	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NGF—atopic dermatitis	0.000177	0.000821	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000176	0.000817	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NGF—atopic dermatitis	0.000173	0.000804	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000173	0.0008	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR5—atopic dermatitis	0.000172	0.000799	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR5—atopic dermatitis	0.000169	0.000782	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—atopic dermatitis	0.000169	0.000781	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NGF—atopic dermatitis	0.000167	0.000775	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—atopic dermatitis	0.000165	0.000765	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR5—atopic dermatitis	0.000163	0.000754	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000146	0.000677	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—atopic dermatitis	0.000146	0.000676	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000143	0.000663	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—atopic dermatitis	0.000139	0.000646	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000138	0.00064	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—atopic dermatitis	0.000133	0.000617	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—atopic dermatitis	0.000133	0.000614	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK8—atopic dermatitis	0.000123	0.000568	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—atopic dermatitis	0.000104	0.000483	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—atopic dermatitis	0.000102	0.000473	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—atopic dermatitis	9.96e-05	0.000462	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—atopic dermatitis	9.91e-05	0.000459	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—atopic dermatitis	9.84e-05	0.000456	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—atopic dermatitis	9.75e-05	0.000452	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—atopic dermatitis	9.7e-05	0.000449	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—atopic dermatitis	9.4e-05	0.000436	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK8—atopic dermatitis	9.17e-05	0.000425	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK8—atopic dermatitis	8.97e-05	0.000416	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK8—atopic dermatitis	8.66e-05	0.000401	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—atopic dermatitis	7.89e-05	0.000366	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—atopic dermatitis	7.83e-05	0.000363	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—atopic dermatitis	5.85e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—atopic dermatitis	5.73e-05	0.000266	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—atopic dermatitis	5.53e-05	0.000256	CbGpPWpGaD
